Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071715 · ClinicalTrials.gov registry record · NA
Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation
A NA study of Phantom Limb Pain and Amputation, Traumatic, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06071715: Completed NA study of Phantom Limb Pain and Amputation, Traumatic, sponsored by University of California, San Diego.
NCT06071715 is a NA study of Phantom Limb Pain and Amputation, Traumatic that has completed, run by University of California, San Diego. The registered enrollment target is 12 participants, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071715, a NA study of Phantom Limb Pain and Amputation, Traumatic, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
When a limb is severed, pain perceived in the part of the body that no longer exists often develops and is called "phantom limb" pain. Unfortunately, phantom pain goes away in only 16% of afflicted individuals, and there is currently no reliable definitive treatment. The exact reason that phantom limb pain occurs is unclear, but when a nerve is cut-as happens with an amputation-changes occur in the brain and spinal cord that actually increase with worsening phantom pain. These abnormal changes may often be corrected by putting local anesthetic-called a "nerve block"-on the injured nerve, effectively keeping any "bad signals" from reaching the brain with a simultaneous resolution of the phantom limb pain. However, when the nerve block resolves after a few hours, the phantom pain returns. But, this demonstrates that the brain abnormalities-and phantom pain-that occur with an amputation are not necessarily fixed, and may be dependent upon the "bad" signals being sent from the injured nerve(s), suggesting that a very long peripheral nerve block-lasting many months rather than hours-may permanently reverse the abnormal changes in the brain, and provide definitive relief from phantom pain. A prolonged nerve block lasting a few months may be provided by freezing the nerve using a process called "cryoneurolysis". The ultimate objective of the proposed research study is to determine if cryoanalgesia is an effective treatment for intractable post-amputation phantom limb pain. The proposed pilot study will include subjects with an existing above-knee amputation who experience intractable daily phantom limb pain. A single ultrasound-guided treatment of cryoneurolysis (or sham block-determined randomly like a flip of a coin) will be applied to the major nerves of the thigh. Although not required, each subject may return 4-6 months later for the alternative treatment (if the first treatment is sham, then the second treatment would be cryoneurolysis) so that all participants have
Primary Outcome
The "average" pain level measured using the numeric rating scale for the previous 24 hours. This is a 0-10 Likert scale measuring pain level with 0=no pain and 10=worst imaginable pain. The primary outcome will be the change from baseline in average pain intensity as measured with the numeric rating scale 1 month following the initial intervention.
Conditions Studied
Interventions
- DEVICE ACTIVE cryoneurolysis
- DEVICE SHAM cryoneurolysis
Study Locations (1)
California
- University of California San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2025-10-09 |
| Phase | NA |
What the finished NCT06071715 record still lists
NCT06071715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (90% lower).
The record links to 4 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 2 interventions - of which ACTIVE cryoneurolysis is the first listed.
NCT06071715 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06071715 about?
NCT06071715 is a clinical study titled "Cryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation". When a limb is severed, pain perceived in the part of the body that no longer exists often develops and is called "phantom limb" pain. Unfortunately, phantom pain goes away in only 16% of afflicted individuals, and there is currently no reliable definitive treatment. The exact reason that phantom li...
What is the current status of trial NCT06071715?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-02-12. Estimated completion is 2025-10-09.
What conditions does trial NCT06071715 study?
This clinical trial studies the following conditions: Phantom Limb Pain, Amputation, Traumatic, Phantom Pain Following Amputation of Lower Limb, Amputation, Surgical.
What interventions are being tested in trial NCT06071715?
The interventions under investigation include: ACTIVE cryoneurolysis (DEVICE), SHAM cryoneurolysis (DEVICE).
Who is sponsoring clinical trial NCT06071715?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06071715 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phantom Limb Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06071715's enrollment target sits among peer trials
12 10th of 12 higher than 3 of 12 other Phantom Limb Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Treatments for Postamputation Pain
RECRUITING · NA
-
Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations
RECRUITING · NA
-
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response
RECRUITING · NA
-
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
ACTIVE NOT RECRUITING · NA
-
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
VR to Evaluate Phantom Limb Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI